Brunn Carsten - Insider Non-Derivative Transactions at Cartesian Therapeutics, Inc. (RNAC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 2, 2024, Brunn Carsten's relationship to Cartesian Therapeutics, Inc. (RNAC) is Director,Officer (President and CEO), and currently has 4,916,056 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RNAC insiders.
Data Source: SEC.
Brunn Carsten - Insider Non-Derivative Transactions of RNAC Common Stock
Brunn Carsten - Insider Non-Derivative Transactions at RNAC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 3, 2024 | Acquisition -- (Common Stock) | 4654100 | 0 | 4916056 |
| Nov 14, 2023 | Disposition -- (Common Stock) | 282800 | 2.06 | 261956 |
| Nov 14, 2023 | Disposition -- (Common Stock) | 169725 | 2.06 | 544756 |
| Nov 14, 2023 | Disposition -- (Common Stock) | 13600 | 2.06 | 714481 |
| Nov 14, 2023 | Disposition -- (Common Stock) | 55000 | 2.06 | 728081 |